Margaret Liu

3.2k citations
107 papers · 2.4k indexed · h-index 27
Topics
Monoclonal and Polyclonal Antibodies Research (9 papers)Nanoplatforms for cancer theranostics (7 papers)Microbial Metabolic Engineering and Bioproduction (7 papers)
Partner nations
United StatesChinaFrance

In The Last Decade

Margaret Liu

100 papers receiving 2.3k citations

Peers

Margaret Liu
Comparison fields: 5 of 144
  • Molecular Biology 983
  • Immunology 428
  • Biomedical Engineering 323
  • Oncology 320
  • Epidemiology 317
Replace Hiroko Tada with:
Hiroko Tada Japan
Ping Zhang China
Yinghua Chen China
Jiayin Shen China
Fei Hao China
Michela Tonetti Italy
Lien Van Hoecke Belgium
Matjaž Jeras Slovenia
Bei Jia China
Paul E. Harris United States
Margaret Liu relative to Hiroko Tada Japan Hiroko Tada's profile →
Citations per field
00.5×3.3×
Hiroko Tada · 1×
Citations per year

Countries citing papers authored by Margaret Liu

Since Specialization
Citations

This map shows the geographic impact of Margaret Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Liu more than expected).

Fields of papers citing papers by Margaret Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Liu. The network helps show where Margaret Liu may publish in the future.

Co-authorship network of co-authors of Margaret Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret Liu. A scholar is included among the top collaborators of Margaret Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret Liu. Margaret Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 6
5 3
6 2
7 7
8 1
9 9
10 2
11 7
12 30
13 4
14 16
15 86
16 14
17 102
18 48
19 14
20 106

About Margaret Liu

Margaret Liu is a scholar working on Virology, Immunology and Oncology, having authored 107 papers that have together received 2.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), Nanoplatforms for cancer theranostics (7 papers) and Microbial Metabolic Engineering and Bioproduction (7 papers). The work is most often cited by research in Immunology (428 citations), Molecular Biology (983 citations) and Oncology (320 citations). Margaret Liu has collaborated with scholars based in United States, China and France. Frequent co-authors include Lufang Zhou, Claire‐Anne Siegrist, Paul‐Henri Lambert, Justin T. Mohr, Xiaohong Chen, Yingnan Si, Seulhee Kim, Ningning Xu, Yan Wu and Hai Wang. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026